Savient Pharmaceuticals - PDFSEARCH.IO - Document Search Engine

Savient Pharmaceuticals
Results: 28

#	Item
11	Microsoft Word - Savient Reports Additional Positive Phase 3 Resultsdoc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 16:59:54 Inborn errors of purine-pyrimidine metabolism Clinical research Uric acid Rheumatology Pegloticase Savient pharmaceuticals Skeletal disorders PEGylation Placebo Clinical trial Hyperuricemia Arthritis
12	Microsoft Word - FDA Arthritis Advisory Committee Recommends Approvaldoc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 16:55:40 Biotechnology Savient pharmaceuticals Pegloticase PEGylation Food and Drug Administration Forward-looking statement Prescription Drug User Fee Act Biopharmaceutical Oxandrolone
13	Microsoft Word - Savient press release re OLEdoc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 17:00:31 Inborn errors of purine-pyrimidine metabolism Rheumatology Uric acid Pegloticase Savient pharmaceuticals PEGylation Clinical trial Tophus Hyperuricemia Allopurinol Oxandrolone Gout
14	Microsoft Word - Savient press release re Rosemont saledoc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 17:00:33 Savient pharmaceuticals American brands Pegloticase Perrigo Forward-looking statement Pharmaceutical industry in China PEGylation
15	Microsoft Word - Savient Receives Complete Response from FDAdoc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 16:59:30 Food and Drug Administration Pharmaceutical industry Clinical research Savient pharmaceuticals Pegloticase PEGylation Prescription Drug User Fee Act Validation Clinical trial
16	Microsoft Word - Savient press release Phase 3 completeddoc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 17:00:19 Clinical research Savient pharmaceuticals Pegloticase PEGylation Clinical trial Placebo
17	Microsoft Word - Savient Receives Positive Opinion for KRYSTEXXA Approval in EU Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 16:59:42 Rheumatology Inborn errors of purine-pyrimidine metabolism Uric acid Pegloticase Savient pharmaceuticals Hyperuricemia Urate oxidase Tophus Gout PEGylation ULT Allantoin
18	Microsoft Word - MVP Receives US Patent on Next-Generation PEG Technology _PharmaPEG_.doc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 16:56:21 Biotechnology PEGylation Pharmacokinetics Pegloticase Patent Savient pharmaceuticals Polyethylene glycol Urate oxidase United States patent law
19	Microsoft Word - Savient Announces PDUFA Date ofondoc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 16:59:18 Savient pharmaceuticals Food and Drug Administration Pegloticase Prescription Drug User Fee Act Forward-looking statement PEGylation
20	Microsoft Word - Savient Provides Update on FDA Meetingdoc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 16:59:29 Pharmaceutical industry Clinical research Savient pharmaceuticals Pegloticase Food and Drug Administration PEGylation Validation Clinical trial

UPDATE